OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda
Sandra A. Springer, Joshua A. Barocas, Alysse G. Wurcel, et al.
The Journal of Infectious Diseases (2019) Vol. 222, Iss. Supplement_5, pp. S230-S238
Open Access | Times Cited: 22

Showing 22 citing articles:

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
Rajesh T. Gandhi, Roger Bedimo, Jennifer Hoy, et al.
JAMA (2022) Vol. 329, Iss. 1, pp. 63-63
Closed Access | Times Cited: 362

A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes
Katelyn F. McNamara, Breanne E. Biondi, Raúl Ulises Hernández‐Ramírez, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 39

Partial-Oral Antibiotic Therapy for Bone and Joint Infections in People With Recent Injection Drug Use
Wei-Teng Yang, Julia C. Dombrowski, Sara N. Glick, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 9

Integrated Care Models: HIV and Substance Use
Katherine Hill, Irene Kuo, Sheela Shenoi, et al.
Current HIV/AIDS Reports (2023) Vol. 20, Iss. 5, pp. 286-295
Open Access | Times Cited: 9

The Effect of Buprenorphine on Human Immunodeficiency Virus Viral Suppression
Jong-Yeon Kim, Catherine R. Lesko, Anthony T. Fojo, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 11, pp. 1951-1956
Open Access | Times Cited: 17

The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts
Gregg Gonsalves, A. David Paltiel, Thomas Thornhill, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 13

The Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret Shopping
Malcolm J. Blough, Amanda Rocha, Jeffrey Bratberg, et al.
Substance Use & Addiction Journal (2024) Vol. 45, Iss. 2, pp. 201-210
Open Access | Times Cited: 1

The Impact of Global Human Rights Advocacy on State Practices: A Multi-Country Study
Feibe Engeline Pijoh
The Easta Journal Law and Human Rights (2023) Vol. 1, Iss. 03, pp. 166-175
Open Access | Times Cited: 2

Time trends and associated factors of global burden due to drug use disorders in 204 countries and territories, 1990–2019
Aiming Chen, Minjie Zou, Min Fan, et al.
Drug and Alcohol Dependence (2022) Vol. 238, pp. 109542-109542
Closed Access | Times Cited: 3

Perspectives on benefits and risks of creation of an “injection drug use” billing code
Gayathri Sundaram, Taisuke Sato, David Goodman‐Meza, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 164, pp. 209392-209392
Closed Access

Considerations when prescribing opioid agonist therapies for people living with HIV
Adati Tarfa, Audun J Lier, Sheela Shenoi, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 7, pp. 549-564
Closed Access

HIV and Substance Use Disorders
Audun J Lier, Adati Tarfa, Sheela Shenoi, et al.
Infectious Disease Clinics of North America (2024) Vol. 38, Iss. 3, pp. 599-611
Closed Access

Serious Opioid Injection-Related Infection and Initiation of Medication for Opioid Use Disorder
Sandra A. Springer
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2421640-e2421640
Open Access

Infectious Diseases fellowship training in caring for people who use drugs: A national assessment of an emerging training need
Shilpa Vasishta, Raagini Jawa, Sarah Kurz, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 10
Open Access

Plans to end HIV should address substance use
Sandra A. Springer
The Lancet HIV (2024) Vol. 11, Iss. 12, pp. e792-e793
Closed Access

Cross-training needs among community-based clinicians in HIV and substance use
Kasey Claborn, Kelli Scott, Sara J. Becker
BMC Medical Education (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use Disorder
Audun J Lier, Brent Vander Wyk, Angela Di Paola, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 1

Trends and characteristics of primary pyogenic spine infections among people who do and do not inject drugs: Northeast New York State, 2007 to 2018
Steven Sola, Casey M. O’Connor, Leigh A. Farry, et al.
Therapeutic Advances in Infectious Disease (2022) Vol. 9
Open Access

Cross-Training Needs Among Community-Based Clinicians in HIV and Substance Use
Kasey Claborn, Kelli Scott, Sara J. Becker
Research Square (Research Square) (2021)
Open Access

Page 1

Scroll to top